Dabucon, Nereka M.

HRN: 25-35-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
CEFIXIME 200MG (CAP)
07/04/2024
07/11/2024
PO
400mg
BID
CKD; CAP-MR
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: